STOCK TITAN

Cannara Biotech to Host Investor Webcast on June 25th, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Cannara Biotech (LOVFF), a vertically integrated premium cannabis producer with two mega facilities in Québec totaling over 1,650,000 sq. ft, has announced an upcoming investor webcast scheduled for June 25, 2025, at 2:00 PM ET. During the presentation, CFO Nicholas Sosiak will discuss key aspects of Cannara's business operations, followed by an interactive Q&A session with investors. The webcast will be accessible through a pre-registration link, and an archived version will be available on the company's investor relations website.
Cannara Biotech (LOVFF), produttore premium di cannabis integrato verticalmente con due mega strutture in Québec che coprono oltre 1.650.000 piedi quadrati, ha annunciato un webcast per investitori previsto per il 25 giugno 2025 alle 14:00 ET. Durante la presentazione, il CFO Nicholas Sosiak illustrerà gli aspetti chiave delle operazioni aziendali di Cannara, seguito da una sessione interattiva di domande e risposte con gli investitori. Il webcast sarà accessibile tramite un link di preregistrazione, e una versione registrata sarà disponibile sul sito web delle relazioni con gli investitori della società.
Cannara Biotech (LOVFF), un productor premium de cannabis integrado verticalmente con dos mega instalaciones en Québec que suman más de 1,650,000 pies cuadrados, ha anunciado una próxima transmisión web para inversores programada para el 25 de junio de 2025 a las 2:00 PM ET. Durante la presentación, el CFO Nicholas Sosiak hablará sobre aspectos clave de las operaciones comerciales de Cannara, seguido de una sesión interactiva de preguntas y respuestas con los inversores. La transmisión será accesible mediante un enlace de preregistro, y una versión archivada estará disponible en el sitio web de relaciones con inversores de la compañía.
Cannara Biotech(LOVFF)는 퀘벡에 165만 평방피트 이상의 두 개의 대규모 시설을 보유한 수직 통합 프리미엄 대마초 생산업체로, 2025년 6월 25일 오후 2시(동부시간)에 예정된 투자자 웹캐스트를 발표했습니다. 발표 중 CFO인 Nicholas Sosiak가 Cannara의 주요 사업 운영 사항을 설명하고, 이후 투자자들과의 실시간 질의응답 세션이 진행됩니다. 웹캐스트는 사전 등록 링크를 통해 접속할 수 있으며, 녹화본은 회사 투자자 관계 웹사이트에서 제공될 예정입니다.
Cannara Biotech (LOVFF), producteur premium de cannabis intégré verticalement avec deux méga installations au Québec totalisant plus de 1 650 000 pieds carrés, a annoncé un webinaire pour investisseurs prévu le 25 juin 2025 à 14h00 ET. Lors de cette présentation, le CFO Nicholas Sosiak abordera les aspects clés des opérations commerciales de Cannara, suivi d'une session interactive de questions-réponses avec les investisseurs. Le webinaire sera accessible via un lien de préinscription, et une version enregistrée sera disponible sur le site web des relations investisseurs de la société.
Cannara Biotech (LOVFF), ein vertikal integrierter Premium-Cannabisproduzent mit zwei Mega-Anlagen in Québec mit einer Gesamtfläche von über 1.650.000 Quadratfuß, hat eine bevorstehende Investoren-Webcast für den 25. Juni 2025 um 14:00 Uhr ET angekündigt. Während der Präsentation wird CFO Nicholas Sosiak wichtige Aspekte der Geschäftstätigkeit von Cannara erläutern, gefolgt von einer interaktiven Fragerunde mit den Investoren. Der Webcast ist über einen Vorregistrierungslink zugänglich, und eine archivierte Version wird auf der Investor-Relations-Website des Unternehmens verfügbar sein.
Positive
  • None.
Negative
  • None.

MONTREAL, June 19, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft, today announced that it will host a webcast investor presentation on Wednesday, June 25, 2025, at 2:00 PM ET. During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key areas of Cannara's business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A session. To listen to the webcast or to ask questions during the live event, please pre-register at the following link:

Webcast Link: https://us02web.zoom.us/webinar/register/WN_Mtb2nKLNTOG0yv96OFdYdw

An archived version of the webcast and presentation will be available on the Company's website, https://investors.cannara.ca/

CONTACT

Nicholas Sosiak, CPA, CA
Chief Financial Officer
nick@cannara.ca 
Zohar Krivorot 
President & Chief Executive Officer 
zohar@cannara.ca 


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

ABOUT CANNARA

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.


FAQ

When is Cannara Biotech (LOVFF) hosting its investor webcast in 2025?

Cannara Biotech is hosting its investor webcast on Wednesday, June 25, 2025, at 2:00 PM ET.

Who will be presenting at the Cannara Biotech (LOVFF) investor webcast?

Nicholas Sosiak, Chief Financial Officer of Cannara Biotech, will be conducting the presentation.

How large are Cannara Biotech's (LOVFF) facilities in Quebec?

Cannara Biotech operates two mega facilities in Quebec spanning over 1,650,000 square feet.

Where can investors access the archived version of Cannara Biotech's (LOVFF) webcast?

The archived version of the webcast and presentation will be available on the company's website at https://investors.cannara.ca/
Cannara Biotech

OTC:LOVFF

LOVFF Rankings

LOVFF Latest News

LOVFF Stock Data

85.56M
46.16M
49.17%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Saint-Laurent